Mabwell and DP Technology Collaborate to Build Biopharma AI Platform for Drug Development
Chinese companies Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) and DP Technology have entered into...
Deals
Jiangxi Institute of Biological Products Files for Hong Kong IPO Amid Strong Market Position
Jiangxi Institute of Biological Products Inc., China’s largest provider and exporter of human tetanus antitoxin...
Zhaoke Ophthalmology Launches Phase II Study for Brimochol PF in Presbyopia Treatment
Zhaoke Ophthalmology Ltd (HKG: 6622) has announced the initiation of a multi-center, double-blinded, crossover, placebo-controlled...
Pierre Fabre and RedRidge Bio Partner on Biparatopic Antibody Development for Precision Oncology
France’s Pierre Fabre Laboratories has entered into a strategic partnership with Switzerland-based RedRidge Bio AG...
INTCO Medical and JD Healthcare Partner to Innovate ‘Internet + Healthcare’ Service Models
China-based INTCO Medical (SHE: 300677), a high-tech manufacturer of medical consumables and equipment, has entered...
iRegene Therapeutics Secures RMB 100 Million in Series B+ Financing to Advance iPSC Technology
Wuhan-based iRegene Therapeutics, a pioneer in AI-powered, chemically induced cell therapies, has reportedly raised close...
Nona Biosciences and Atossa Therapeutics Forge Partnership to Advance Breast Cancer Therapies
Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Ltd (HKG: 2142), has entered into a...
Astellas Pharma Partners with Shanghai Pharma on Zolbetuximab Commercialization
Japan-based Astellas Pharma Inc. (TYO: 4503) announced a strategic partnership with Shanghai Pharmaceuticals (SPH; SHA:...
Sinopep-Allsino Partners with Gulf Pharmaceutical for Semaglutide API Supply
Jiangsu-based Contract Development and Manufacturing Organization (CDMO) Sinopep-Allsino Biopharmaceutical Co., Ltd (SHA: 688076) has signed...
Shanghai Kehua Bioengineering Launches Xi’an Medical Complex Project
Shanghai Kehua Bioengineering Co., Ltd (SHE: 002022), a leading Chinese biotechnology company, has announced plans...
HuidaGene’s hfCas12Max Licensed to Vita Therapeutics for Neuromuscular Cell Therapy
Shanghai-based genome medicines specialist HuidaGene Therapeutics has sublicensed its hfCas12Max platform to Vita Therapeutics, Inc.,...
Aidea Pharma Terminates COVID-19 Drug Collaboration with PharmaBlock
China-based Jiangsu Aidea Pharmaceutical Co., Ltd (SHA: 688488) announced the termination of its development collaboration...
IDT and Shanghai Bioscience Forge Partnership to Drive Local Innovation in China
Integrated DNA Technologies (IDT), a leading life sciences and diagnostics company under the Danaher Corporation...
TJ Biopharma Partners with Biogen on Felzartamab Phase III Studies in China
China-based TJ Biopharma has entered into an agreement with US-based Biogen Inc. (NASDAQ: BIIB) to...
Novo Nordisk Partners with Tencent Healthcare for Weight Management Initiative in China
In alignment with China’s “Weight Management Year” initiative, Denmark-based Novo Nordisk A/S (NYSE: NVO) has...
Siemens Set to Acquire Dotmatics for $5.1 Billion to Boost Life Sciences R&D
German industrial giant Siemens AG (ETR: SIE) has announced plans to acquire US-based Dotmatics, a...
Lynmou Medical Secures Series A Funding for Endoscope Expansion
Lynmou Medical, a Hangzhou-based provider of soft endoscope solutions, has reportedly secured “tens of millions”...
Hengrui Pharmaceuticals Licenses SHR7280 to Merck for Assisted Reproduction
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) has entered into a licensing agreement with...
Duality Biotherapeutics Makes Hong Kong IPO Debut with ADC Pipeline
China-based Duality Biotherapeutics, Inc. (HKG: 9606) successfully debuted in Hong Kong after completing an initial...
ABL Bio and GSK Partner on Neurodegenerative Disease Therapies with Grabody-B Platform
South Korea-based clinical-stage biotech ABL Bio Inc. (KOSDAQ: 298380) has entered into a licensing agreement...